Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.930
-0.830 (-30.07%)
At close: Sep 3, 2026, 4:00 PM EDT
2.010
+0.080 (4.15%)
After-hours: Sep 3, 2026, 7:59 PM EDT

CNTB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
122158----
Market Cap Growth
------
Enterprise Value
91104----
Last Close Price
1.932.82----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
PS Ratio
41.162463.25----
PB Ratio
4.523.76----
P/TBV Ratio
4.533.76----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
EV/Sales Ratio
30.701619.50----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Debt / Equity Ratio
0.020.020.000.010.000
Net Debt / Equity Ratio
-1.15-1.04-1.01-1.16-0.96-0.98
Net Debt / EBITDA Ratio
0.440.765.031.721.322.75
Net Debt / FCF Ratio
0.510.853.842.461.443.04
Asset Turnover
0.050.000.23---
Quick Ratio
2.113.2711.204.699.7615.30
Current Ratio
2.373.7411.464.859.9715.30
Return on Equity (ROE)
-140.51%-82.72%-16.14%-47.96%-54.96%-364.72%
Return on Assets (ROA)
-69.75%-46.13%-10.52%-28.64%-31.27%-26.43%
Return on Capital Employed (ROCE)
-259.20%-136.80%-20.70%-67.60%-73.50%-35.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Earnings Yield
-56.76%-35.19%----
FCF Yield
-49.89%-32.76%----
Buyback Yield / Dilution
-4.44%-0.81%-0.27%-0.04%-5.50%-205.31%
SEC Filings: 10-K · 10-Q